Cancer
Neoplasm of Uncertain Histogenesis
CI-CAN-00000034Explore in graph →
Non-malignant20,280 active trials259 approved drugs3,813 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00000034Explore in graph →
Clinical trials
91,351 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00005947 | Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 3 | 127 | DendreonINDUSTRY | 1 | Nov 1, 2010 | clinicaltrials |
| NCT00455936 | First-line Gefitinib Versus Chemotherapy for Lung Adenocarcinoma in Never Smoker | completed | Phase 3 | 315 | National Cancer Center, KoreaOTHER_GOV | 1 | Oct 25, 2010 | clinicaltrials |
| NCT00221702 |
| PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)(EADO) |
| completed |
| Phase 3 |
| 898 |
| University Hospital, BordeauxOTHER |
| 1 |
| Oct 13, 2010 |
| clinicaltrials |
| NCT00230646 | Promoting Physical Activity After Colorectal Cancer | completed | Phase 3 | 46 | The Miriam HospitalOTHER | 1 | Oct 5, 2010 | clinicaltrials |
| NCT00045292 | Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation | completed | Phase 3 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Sep 21, 2010 | clinicaltrials |
| NCT00471965 | Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma Patients(EACH) | completed | Phase 3 | 371 | SanofiINDUSTRY | 4 | Sep 20, 2010 | clinicaltrials |
| NCT00524849 | Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis | completed | Phase 2 / Phase 3 | 60 | Fudan UniversityOTHER | 1 | Sep 14, 2010 | clinicaltrials |
| NCT00598312 | Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer | completed | Phase 3 | 201 | Oakwood Laboratories, LLCINDUSTRY | 1 | Sep 8, 2010 | clinicaltrials |
| NCT00065442 | Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy | completed | Phase 3 | 512 | DendreonINDUSTRY | 2 | Sep 6, 2010 | clinicaltrials |
| NCT00312819 | Initial Assessment of the Effect of the Addition of Disulfiram (Antabuse) to Standard Chemotherapy in Lung Cancer | completed | Phase 2 / Phase 3 | 60 | Hadassah Medical OrganizationOTHER | 1 | Aug 31, 2010 | clinicaltrials |
| NCT01186081 | Comparison of Preoperative and Postoperative Radiotherapy and Capecitabine in Locally Advanced Rectal Cancer | completed | Phase 3 | 240 | Asan Medical CenterOTHER | 1 | Aug 23, 2010 | clinicaltrials |
| NCT00440414 | Trial of Pemetrexed Versus Erlotinib in Pretreated Patients With Non Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 320 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00469443 | Randomized Phase III Study of Folfiri+Avastin Versus Xeliri+Avastin as 1st Line Treatment of CRC | completed | Phase 3 | 330 | Hellenic Oncology Research GroupOTHER | 1 | Aug 19, 2010 | clinicaltrials |
| NCT00201916 | Shorter Radiation Schedule for the Treatment of Prostate Cancer | completed | Phase 3 | 936 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Aug 17, 2010 | clinicaltrials |
| NCT00074204 | Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | completed | Phase 3 | 17 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 16, 2010 | clinicaltrials |
| NCT00189306 | Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream | completed | Phase 3 | 169 | Graceway Pharmaceuticals, LLCINDUSTRY | 2 | Aug 10, 2010 | clinicaltrials |
| NCT00668616 | Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes | completed | Phase 3 | 1,034 | North Eastern German Society of Gynaecological OncologyOTHER | 1 | Jul 29, 2010 | clinicaltrials |
| NCT00193362 | Study of Paclitaxel, Carboplatin, and Gemcitabine Versus Gemcitabine and Vinorelbine for Non-Small Cell Lung Cancer | completed | Phase 3 | 200 | SCRI Development Innovations, LLCOTHER | 0 | Jul 28, 2010 | clinicaltrials |
| NCT00607295 | Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients | completed | Phase 3 | 98 | Seoul National University HospitalOTHER | 1 | Jul 27, 2010 | clinicaltrials |
| NCT00129519 | A Study to Evaluate the Effectiveness of Imiquimod 5% Cream for Basal Cell Carcinoma Recurrence | completed | Phase 3 | 63 | Graceway Pharmaceuticals, LLCINDUSTRY | 1 | Jul 16, 2010 | clinicaltrials |
| NCT00486473 | Multihance Versus Magnevist in Breast MRI(DETECT) | completed | Phase 3 | 130 | Bracco Diagnostics, IncINDUSTRY | 1 | Jul 15, 2010 | clinicaltrials |
| NCT00083876 | D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma | completed | Phase 3 | 500 | University of ArkansasOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00093028 | Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II | completed | Phase 3 | 315 | University of ArkansasOTHER | 1 | Jul 2, 2010 | clinicaltrials |
| NCT00002517 | Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome | completed | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 3 | Jun 22, 2010 | clinicaltrials |
| NCT00417911 | Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients | completed | Phase 3 | 400 | Nordic Myeloma Study GroupOTHER | 5 | Jun 22, 2010 | clinicaltrials |
| NCT01148446 | R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL(ANZINTER3) | completed | Phase 3 | 226 | Fondazione Italiana Linfomi - ETSOTHER | 1 | Jun 22, 2010 | clinicaltrials |
| NCT01016548 | Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy | completed | Phase 3 | 42 | University Health Network, TorontoOTHER | 1 | Jun 4, 2010 | clinicaltrials |
| NCT00606619 | Effects of Early Oral Feeding After Resection of Gastric Cancer | completed | Phase 3 | 58 | The Catholic University of KoreaOTHER | 1 | May 28, 2010 | clinicaltrials |
| NCT00440089 | Effects of Hands-on-Healing vs. Touch for Fatigued Breast Cancer Survivors | completed | Phase 2 / Phase 3 | 76 | University of California, San DiegoOTHER | 1 | May 25, 2010 | clinicaltrials |
| NCT00003328 | Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer | completed | Phase 3 | 600 | Boehringer IngelheimINDUSTRY | 1 | May 21, 2010 | clinicaltrials |
| NCT01124253 | Adjuvant Vinorelbine Plus Cisplatin(NP) Versus NP Plus Endostar in Patients With Completely Resected Stage IB-IIIA Non-small Cell Lung Cancer(NSCLC)(Dengshan) | completed | Phase 3 | 250 | Shanghai Jiao Tong University School of MedicineOTHER | 1 | May 17, 2010 | clinicaltrials |
| NCT00219973 | CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) | completed | Phase 3 | 526 | Rovi Pharmaceuticals LaboratoriesINDUSTRY | 4 | Apr 28, 2010 | clinicaltrials |
| NCT00364455 | Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer. | completed | Phase 3 | 56 | Janssen-Ortho Inc., CanadaINDUSTRY | 0 | Apr 27, 2010 | clinicaltrials |
| NCT00061815 | Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer | completed | Phase 3 | 102 | Eli Lilly and CompanyINDUSTRY | 1 | Apr 12, 2010 | clinicaltrials |
| NCT00063141 | Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer | completed | Phase 3 | 1,302 | Eli Lilly and CompanyINDUSTRY | 17 | Apr 12, 2010 | clinicaltrials |
| NCT00037713 | Survival in a Randomized Phase III Trial in Patients With Limited Disease (LD) Small Cell Lung Cancer Vaccinated With Adjuvant BEC2 and BCG | completed | Phase 3 | 515 | Eli Lilly and CompanyINDUSTRY | 0 | Apr 8, 2010 | clinicaltrials |
| NCT00003883 | Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation | completed | Phase 3 | 578 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00003972 | Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage II or Stage IIIA Breast Cancer | completed | Phase 3 | 280 | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00014391 | Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation | completed | Phase 3 | — | Fred Hutchinson Cancer CenterOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00222053 | IFM 99-02 Thalidomide in Myeloma | completed | Phase 3 | 800 | University Hospital, ToulouseOTHER | 1 | Apr 2, 2010 | clinicaltrials |
| NCT00002789 | Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia | completed | Phase 3 | 100 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 30, 2010 | clinicaltrials |
| NCT00180089 | Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation | completed | Phase 3 | 242 | Technische Universität DresdenOTHER | 1 | Mar 30, 2010 | clinicaltrials |
| NCT00314977 | Sequential vs Upfront Intensified Neoadjuvant Chemotherapy in Patients With Large Resectable or Locally Advanced Breast Cancer.(INTENS) | completed | Phase 3 | 200 | Radboud University Medical CenterOTHER | 1 | Mar 18, 2010 | clinicaltrials |
| NCT00179647 | Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma | completed | Phase 3 | 1,913 | Celgene CorporationINDUSTRY | 2 | Mar 16, 2010 | clinicaltrials |
| NCT01085058 | Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy(CU01) | completed | Phase 2 / Phase 3 | 169 | WiSP Wissenschaftlicher Service Pharma GmbHOTHER | 0 | Mar 11, 2010 | clinicaltrials |
| NCT00048841 | Prevention of Osteoporosis in Men With Prostate Cancer | completed | Phase 3 | 112 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00003187 | Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma | completed | Phase 2 / Phase 3 | 19 | Virginia Commonwealth UniversityOTHER | 1 | Feb 24, 2010 | clinicaltrials |
| NCT00790322 | Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation Therapy | completed | Phase 3 | 130 | Biotec Pharmacon ASAINDUSTRY | 1 | Feb 19, 2010 | clinicaltrials |
| NCT00143455 | Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer | completed | Phase 3 | 485 | PfizerINDUSTRY | 13 | Feb 18, 2010 | clinicaltrials |
| NCT01070862 | Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies.(MAG 2002) | completed | Phase 3 | — | University Hospital, CaenOTHER | 1 | Feb 18, 2010 | clinicaltrials |
Data updated 23 days agoSource updated Nov 1, 2010source: clinicaltrials